CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

NGENNERVGEN PHARMA CORP.

NASDAQ · Pharmaceutical Preparations
Last close $1.91 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
INSTITUTIONAL OWNERSHIP
Institutional holders62
Shares held11,993,602
Value$24.67M
Percent of shares outstanding15.06%
As of quarter end2026-06-30
RECENT NEWS
  • NervGen Pharma: The Upside Is Large, But Phase 3 Decides Everything
  • NervGen Pharma Corp. (NGEN) Discusses Challenges and Advances in Drug and Therapy Trials for Spinal Cord Injury Transcript
  • NervGen to restate 2025 annual and Q2 2026 interim financials
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
NERVGEN PHARMA CORP. (NGEN) · Stock Price, Institutional Holdings, News · CatalystPit